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Introduction
Cancer incidence is one of the most pressing problems 
of modern medicine. According to the International Agency 
for Research on Cancer GLOBOCAN, there will be an esti-
mated 18.1 million new cancer cases (excluding 17.0 million 
nonmelanoma skin cancers) in 2018. Cancer is the second 
leading cause of death globally. The 2018 statistics show that 
cancer was responsible for an estimated 9.6 million deaths, 
and about 1 in 6 deaths was due to cancer [1]. In 2016, in 
the Russian Federation, the number of new registered cas-
es of malignant neoplasms increased by 1.7% compared to 
2015, and was by 20.6% higher than in 2006 [2]. Economic 
losses associated with this pathology are significant and are 
increasing each year. In 2010, the total annual economic cost 
of cancer diagnosis and treatment was estimated at U.S. $ 
1.16 trillion [3]. 
Despite huge financial resources invested in the field of 
cancer research, the leading U.S. centers have noted a steady 
decline in the incidence of low-risk cancers and an absolute 
increase in intermediate and high-risk cancers. For instance, 
the proportion of low-grade prostate cancer with Gleason 
score 3+3 cancers decreased by 2012 from 30.2% to 17.1% in 
subsequent years while high-grade Gleason score 8+ cancers 
increased by 2012 from 6.2% to 17.5% today. At the same 
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Abstract
Background: Despite significant financial resources invested in the field of cancer research, there has been a steady increase in the registration of new 
cases of malignant neoplasms. Modern technical capabilities for analyzing the molecular substrate of tumor genesis have revealed a large number of such 
factors. The latest studies point out the paramount importance of the integral bioelectric field as contrasted with molecular mechanisms in oncopathology. 
Clear evidence has emerged that the “decision” of a certain part of the body to develop a tumor depends on the bioelectric state of remote regions. In 
the light of these findings, it becomes obvious that the difficulties in solving the cancer problem are associated with a simplified approach focused only 
on molecular components.
Conclusions: It can be assumed that the difficulties in solving the cancer problem are associated with a simplified approach, focused only on molecular 
components. It is difficult to identify clear differences between the blastomic and healthy cells, as they work according to the same biological principles, 
although differently expressed. Despite functioning with almost identical molecular components, tumor and healthy tissues differ significantly in the 
dynamics of growth and pattern formation. The above data indicates that the “decision” of a certain part of the body to develop a tumor depends on the 
bioelectric state of remote regions. In this context, the prognosis and treatment of malignant neoplasms can most likely be achieved not by local, gene-
targeting technology, but by methods for the detection of tumor signatures in the morphogenetic field of the organism.
Key words: carcinogenesis, bioelectric patterns, non-coding RNAs. 
time, the authors note an increase by 24% in absolute num-
bers of GS8+ group [4]. 
The launch of the Human Protein Atlas ushered in a new 
era in the fight against cancer [5]. Decoding the human ge-
nome has become possible due to the next-generation se-
quencing (NGS) methods. The technology allows describing 
the primary structure of DNA and RNA. The main differ-
ence from earlier sequencing techniques is the possibility 
to “read” several sections of the genome simultaneously. A 
single instrument run of the NGS generates up to hundreds 
of megabases and gigabases of nucleotide sequence [6]. The 
description of the human genome has made it possible to de-
tect abnormal behaviour of proteins in different cancers [7]. 
Using these technologies, Japanese researchers have iden-
tified independent oncogene panels and have compiled the 
first guidance for the diagnosis, treatment and prognostic 
evaluation of oncological diseases. The guidance describes 
how to use the outcomes of gene panels testing according to 
the type of blastomic process: childhood cancer, rare cancer, 
cancer of unknown primary, and cancer of unknown etiol-
ogy [8].
Another facet of genetics research concerns changes 
of microsatellites – repetitive DNA segments (ranging in 
length from 1-6 or more base pairs) [9, 10]. These repeats are 
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found in numerous places in the genome, and have a higher 
mutation rate than other regions of DNA [11]. 
According to Wadhwa N et al. [12], a set of microsatellite 
markers (D9S63, D9S156, and D9S283) can be used to detect 
bladder cancer in high-risk population.
The most important methods for early cancer detection 
and prediction include identification of specific compounds 
circulating in the body – products of the cancerous process. 
Recent studies reveal a number of RNA molecules that 
do not encode proteins as tumor markers. Such RNAs can be 
structural components of organelle (ribosomal RNA), par-
ticipate in protein synthesis, (transfer RNA), have enzymatic 
activity, or perform regulatory functions by influencing on 
chromatin structure. The non-coding RNAs include: trans-
fer RNAs (tRNA), ribosomal RNAs (rRNA), small nuclear 
RNAs (snRNA), small nucleolar RNA (snoRNA), antisense 
RNA (aRNA), micro RNA (miRNA), small interfering RNA 
(siRNA), piwi-interacting RNA (piRNA), long noncoding 
RNA (IncRNA) – Xist, Evf, Air, CTN, PINK, TUG1 [13].
These compounds can act both as oncogenes and as on-
cosuppressors [14, 15]. The scientists [16] have studied the 
effect of long non-coding RNA (lncRNA) H19 on the epithe-
lial-mesenchymal transition (EMT) process in patients with 
colorectal adenocarcinoma (CRA). Genetic analysis showed 
that high expression of IncRNA H19 was observed in pa-
tients with poorly differentiated tumors and lymph node 
metastases. In the given group of patients, this indicator was 
also an independent predictor of adverse outcome of the 
disease. According to researchers, IncRNA H19 can be used 
as a potential biomarker for the diagnosis and treatment of 
colorectal adenocarcinoma. 
Similar results are provided by the authors [17]. Accord-
ing to their opinion, overexpression of the microRNA miR-
3148 promotes an increased resistance of cancer cells under 
conditions of hypoxia and starvation.
A comparative study of the exhaled-breath-condensate 
(EBC) proteome was carried out using the method of ion 
cyclotron resonance mass spectrometry with electrospray 
ionization in four donor groups: patients diagnosed with 
lung cancer, patients with chronic obstructive pulmonary 
disease, community-acquired pneumonia, and healthy non-
smokers [18]. More than 300 proteins were identified, while 
19 of them were found in the EBC samples of the donors 
who were diagnosed with early stage lung cancer and are 
potentially significant in the development of a diagnostic 
lung-cancer biomarker panel. Thus, the EBC analysis could 
be a promising non-invasive method for early diagnosis of 
lung cancer, since the EBC protein profiles of different donor 
groups can be distinguished. There is a possibility of iden-
tifying a specific group of proteins inherent in a particular 
condition in respiratory diseases. 
The use of optogenetics in the study of cell biology has 
increased in recent years. The method is based on the in-
troduction of special channelopsins into the cytomembrane 
that respond to light excitation; channelrhodopsin was the 
first opsin used. Genetic engineering is applied for building 
of these structures [19]. Optogenetics can be used to disclose 
important information about signal transduction networks 
within cells under normal and pathological conditions [20]. 
Using this technology, the authors [21] have noted a change 
in the duration and frequency of the extracellular signal-
regulated kinase (ERK) in tumor cells. In particular, blast 
cells that harbor particular B-Raf mutations (in the kinase 
P-loop) exhibit a substantially slowed kinetics of inactivation 
of the dynamic signal (half-time for signal decay is 10-fold 
longer). In these cancer cells, the active ERK output signal 
remains abnormally high for ,20 min compared with 1 to 2 
min for normal cells.
Signal transduction is the process by which various types 
of signals (chemical, physical) are transmitted through a 
cell as a series of molecular events (most commonly pro-
tein phosphorylation), which ultimately results in a cellular 
response [22]. When signaling pathways interact with each 
other, they form networks, which allow cellular responses to 
be coordinated [23]. Gene activation and metabolism are ex-
amples of cellular responses to extracellular stimulation that 
require signal transduction. Thus, the initial impulse can ac-
tivate the expression of a large number of genes, which leads 
to various physiological processes [24, 25].
According to the transcription process and biochemical 
cascades depend on the electrical potential of the cells and 
cell-cell interactions [26, 27, 28, 29, 30]. The electrical poten-
tial of a histiocyte is expressed by membrane voltage (Vm). 
The latter value is defined as the difference in electrical poten-
tial between the cytoplasm and the extracellular space [31]. 
The hypothesis that biological information can be trans-
mitted by electricity was first proved in the late 1700s, when 
Luigi Galvani electrically stimulated muscle contraction in 
an amputated frog’s leg [32]. Electrical properties are often 
associated only with excitable cells such as neurons. How-
ever, all cells possess an electrical potential across the mem-
brane, and thus generate and receive bioelectric signals [33].
Evidence that the electric field can serve as a vector and 
conductor-morphogen for growth and regeneration of the 
soma was first provided by A.P. Matthews in 1903 when he 
determined the electrochemical gradient in the regenerat-
ing hydra [34]. Modern studies confirm the thesis that these 
voltage gradients can predict morphology, providing infor-
mation on the structure, growth and formation of the organ-
ism as a whole [35, 36]. 
The significance of bioelectrical potential of the cell for 
its further differentiation and the morphogenesis of the or-
ganism is revealed by the results of researchers’ experiments 
[37]. Using fluorescent voltage reporters CC2-DMPE and 
DiBAC4, bioelectric phenomena were investigated during 
normal development in Xenopus embryos. The images of 
embryos developing from gastrula to tailbud stages revealed 
remarkable, never-before-seen patterns of hyper΄and de-
polarized subpopulations of visible ectodermal cells. Three 
courses of hyperpolarization were distinguished during the 
entire period of animal development. Course I was a wave 
that moved across the entire embryo, apparently coincident 
with the appearance of cilia at the blastula surface and the 
beginning of neurulation. Course II, being distinguished by 
a bright signal coming from the median ectoderm, accom-
panied the closure of the neural tube.
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Course III represented a series of hyper-polarizations in 
multiple smaller areas and coincided with the change of em-
bryonic shape from spherical to elongate. For example, the 
intense region of hyperpolarization of a certain group of cells 
marked the future stomodeum. The neighboring cells that 
did not contribute to this structure remained relatively de-
polarized. 
To sum up, the authors argue that bioelectric patterns de-
limit the “precursor fields” – that is to say, regions within the 
embryo consisting of cells whose offspring will produce spe-
cific morphological features, and they can be distinguished 
from the neighboring cells or regions. 
The results of the experiments also provide evidence that 
Vm is a field of morphogen that controls development at 
both cellular and tissue levels, and is not a simple cellular 
“switch” (Pai et al., 2015) [38]. The authors observed wide-
spread apoptosis or proliferation in the adult central nervous 
system by the overexpression of hyperpolarizing channels in 
the blast cells of the frog embryo.
The electrical potential of Vm represents the long-term, 
slowly changing bioelectric gradient in non-excitable cells 
[39], and controls critical cell functions including prolifera-
tion, migration, and differentiation [40, 41]. Recent studies 
have also demonstrated that Vm is able to control wound 
healing, either directly or indirectly [42].
In the late 1960s, while studying mitotic activities in 
sarcoma cells, Clarence D. Cone Jr. [43] reported that Vm 
underwent hyperpolarization before entering M phase, and 
suggested that the level of Vm is correlated with cell cycle 
progression. Cone’s theory [44] was supported by several 
previous studies, which demonstrated significant Vm depo-
larization during malignant transformation of normal cells 
[45, 46]. Direct in vitro and in vivo comparisons of Vm levels 
between normal hepatocytes and hepatocellular carcinoma 
cells [47], normal and neoplastic adrenocortical tissues) 
[48], normal embryonic fibroblasts and fibrosarcomas [49] 
showed that cancer cells tended to be more depolarized than 
their normal counterparts. 
The experimental findings serve as a good example of the 
significance of Vm in tumor genesis [50]. Scientists induced 
tumor-like structures (ITLSs) in Xenopus model by over-
expression of various oncogenes, such as Xrel3, Gli1, p53 
(Trp248) and KrasG12D, associated with the development 
of melanoma, leukemia, lung cancer and rhabdomyosarco-
ma. Microinjection of mRNAs encoding these genes into a 
single blastomere resulted in clearly identifiable ITLS. The 
authors revealed that induced tumor-like structures (ITLSs) 
generated by overexpression of Xrel3 are clearly demarcated 
from surrounding tissue by a depolarized transmembrane 
potential. The unique depolarization in relation to the sur-
rounding tissue was also observed for Gli1 and KrasG12D 
ITLSs. Experimental findings suggest that the depolarized 
transmembrane potential is a marker of ITLSs regardless of 
its genetic origin.
The importance of the bioelectric field as a formative one 
is also reported by the authors [51]. Investigating the role 
of bioelectric signals in embryogenesis and tumor forma-
tion by modulating chlorine channels, the Vm of individual 
neural crest cells were changed. These structures represent a 
temporary group of cells that arise from the embryonic ec-
toderm. The latter gives rise to multiple cell types, includ-
ing melanocytes, craniofacial bones and cartilage, smooth 
muscle, peripheral and intestinal cells, neurons and glia [52]. 
During the temporary depolarization of the above embryon-
ic cells in vivo, a completely different type of cells (melano-
cytes) acquired a phenotype similar to metastatic melanoma 
[51]. Melanocytes acquired dendritic morphology, increased 
mitotic activity, and penetrated into blood vessels and soft 
tissues, such as the lumen of the neural tube and brain. In 
addition to the appearance of this melanocyte clone, disor-
ganization and ectopic blood vessels growth were also ob-
served [51]. It is important to mention that the same effect 
was obtained using any method of depolarization of Vmem 
(by modulating chlorine, sodium, potassium, or hydrogen 
channels). This in turn indicates the primary role of a purely 
physiological perturbation – disturbance in Vmem in the ap-
pearance of a metastatic phenotype, and not in case of any 
specific gene product or ionic disturbances. Furthermore, 
the authors suggested that forced hyperpolarization can sup-
press tumorigenesis. Various hyperpolarizing ion channels 
and the oncogene Xrel3 were co-injected into a single blas-
tomere of different Xenopus embryos. It has been found that 
hyperpolarization can prevent the formation of tumor-like 
structures, despite the high levels of oncogene expression in 
cells. The use of several different hyperpolarizing channels 
based on Cl− and K+ demonstrated that the suppression of 
neoplastic transformation is due to the Vmem hyperpolar-
ization, and does not depend on the specificity of the ion 
channels.
Furthermore, scientists have complicated the experiment 
with the aim to identify the systemic effects of a single de-
polarized cell of the Xenopus embryo. One cell of embryos 
at the 32-cell stage was microinjected with mRNA encod-
ing the depolarizing channel subunit KCNE1 plus mRNA 
encoding β-galactosidase as a lineage tracer. These embryos 
were then treated with the MMP-blocking compound NSC-
84093, which prevents melanocytes from migrating. As a 
result of the experiment, despite blocking cell migration, 
high-dendritic melanocytes appeared in the head and on the 
opposite side of the experimental animal. The authors con-
clude that depolarized cells can exert their inductive effect at 
a long range, crossing the midline to affect the contralateral 
side. The same conclusion is confirmed by transplantation 
experiments: small fragments of cells from a depolarized 
donor transplanted into an untreated embryo induce host 
melanocytes to arborize and migrate inappropriately [51]. 
The authors [53, 54] also point to the importance of the 
integrity of the bioelectric field. Implanting into connective 
tissue of the experimental rodents rectangles of inert plas-
tic, metal foil, or glass coverslips induces sarcomas when the 
material is >1 cm2. If the material is perforated, the incidence 
is reduced, and the effect is not recapitulated by powders of 
the same material (which actually increases surface area, rul-
ing out chemical induction or genetic damage mechanisms).
In the context of the importance of the problem con-
cerning intercellular communication for tumor genesis and 
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regenerative pattern, we think it necessary to consider the 
early experiments of Seilern-Aspang [55]. The author de-
scribed planarian experiments in which a carcinogen led to 
the formation of many head teratomas with irregular nerves 
and ectopic eyes, and concluded that “the cell-isolating ac-
tion of the carcinogen prevents formation of a single mor-
phogenetic field and leads to the establishment of several 
separated fields of reduced dimensions”.
Consequently, it is possible that the tumor has, in some 
practical sense, its own bioelectric autonomous field. The lat-
ter leads to a loss of integration with the host’s body layout. 
This phenomenon is indirectly confirmed by the fact that, in 
contrast to normal somatic tissues, which are reconstructed 
during transplantation to foreign places [56], the histopath-
ological structure of metastasis reflects the structure of the 
tissue of origin rather than their destination [57].
The view that cancer is a consequence of some failure in 
the geometry of the organism formation is confirmed by the 
reversibility of the cancer process. 
Thus, if intercellular communication failure leads to 
the formation of the tumor, then the presence of a strong 
formation field can presumably inhibit this pathology. This 
hypothesis is proved by embryo experiments, as the mor-
phogenetic field ought to be the most active in this period. 
According to [58, 59], despite high malignancy and euploidy, 
tumor cells integrated into wild-type embryonic hosts have 
become integrated as normal tissue. Equally, the embryonic 
field present in the blastocyst can normalize several types of 
blastoma cells, including cells isolated from embryonic car-
cinoma, leukemia, and neuroblastoma [60].
According to the results of recent studies [61, 62, 63], 
some ion channels have been suggested as potential tumor 
markers. However, as previously described in the examples of 
experiments [51], the same effect was achieved by any meth-
od of depolarization of Vmem (by modulating -chloric, -so-
dium, -calcium or hydrogen channels). The researchers [64] 
also point out the paramount importance of the integral for-
mation field as contrasted with molecular mechanisms at the 
cellular level for the integral development of an individual. 
The scientists’ research was focused on independent methods 
for implementing morphogenesis. For example, renal tubules 
in a triton, having a constant size, can be constructed from 
cells of various sizes, depending on ploidy. Reaching the same 
macroscopic state can be realized by various underlying mo-
lecular mechanisms. Thus, the renal tubules can be formed 
both by bending of the cytoskeleton – twisting one very large 
cell around it, or by numerous small cells. The above discrep-
ancies may, to some extent, explain the absence of a frequent 
direct dependence between the outcome of the cancer pro-
cess and the level of tumor markers. 
Despite significant efforts to identify cancer “triggers”, 
molecular cell substrate studies have been significantly more 
modest. Instead of a small amount of biochemical and ge-
netic indicators of specific blastoma cells, molecular analysis 
of human cancers revealed a much wider variety of such de-
terminants [65]. As noted above, the latest studies identify 
a number of RNA molecules that do not encode proteins as 
tumor markers. According to S.A. Lavrov, et al. [66], inves-
tigated aspects of the effect of non-protein-coding RNA on 
chromatin structure, the actual importance of these process-
es at this stage turns out to be not evaluable, but, undoubt-
edly, enormous.
Similar conclusions can be drawn from the works of 
researchers [67]. The authors studied tissue and plasma 
samples of cancer patients treated with surgical resection us-
ing the next-generation sequencing (NGS) method. When 
somatic alterations identified by each test were combined, 
the total proportion of patients with actionable mutations 
increased to 71.43%. Moreover, variants of unknown signifi-
cance that were assessed as likely pathogenic had a higher 
percentage in ctDNA exclusively.
Conclusions
Summarizing the above, it can be assumed that the dif-
ficulties in solving the cancer problem are associated with 
a simplified approach, focused only on molecular compo-
nents. It is difficult to identify clear differences between the 
blastomic and healthy cells, as they work according to the 
same biological principles, although differently expressed. 
Despite functioning with almost identical molecular com-
ponents, tumor and healthy tissues differ significantly in the 
dynamics of growth and pattern formation. The above data 
indicates that the “decision” of a certain part of the body to 
develop a tumor depends on the bioelectric state of remote 
regions. In this context, the prognosis and treatment of ma-
lignant neoplasms can most likely be achieved not by local, 
gene-targeting technology, but by methods for the detection 
of tumor signatures in the morphogenetic field of the or-
ganism.
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